Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$9.59 - $11.35 $424,395 - $502,282
44,254 New
44,254 $436,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $106,867 - $142,412
11,616 New
11,616 $111,000
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $91,626 - $120,259
10,805 New
10,805 $92,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $176,560 - $277,169
-17,998 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $469,176 - $569,686
-38,807 Reduced 68.32%
17,998 $244,000
Q3 2021

Nov 15, 2021

BUY
$13.25 - $15.13 $182,161 - $208,007
13,748 Added 31.93%
56,805 $770,000
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $558,449 - $695,370
43,057 New
43,057 $615,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Echo Street Capital Management LLC Portfolio

Follow Echo Street Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Echo Street Capital Management LLC with notifications on news.